Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, et al. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol 2021 Dec 2. pii: 6448328. doi: 10.1093.
PMID: 34865129